FDA Drug Application (020259) for MEPRON by GLAXOSMITHKLINE LLC

Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Application Number020259
Product Number001
FormTABLET;ORAL
Dosage250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMEPRON
Active IngredientATOVAQUONE

Active IngredientCount
List of drugs with Active Ingredient ATOVAQUONE5


Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC